Pure Biologics Spólka Akcyjna

Pure Biologics Spólka Akcyjnaverified

PUR.WA

Price:

$4.196

Market Cap:

$33.57M

Pure Biologics Spólka Akcyjna, a biopharmaceutical company, engages in the research and development of biological drugs and non-systematic therapies in the field of immuno-oncology, autoimmunology, and rare diseases. It is involved in the production, purification, analysis, and characterization of antibodies and aptamers; and design, development, and validation of assays, as well as conducts research on technology platforms for selecting active molecules. The company offers PureApta, a modular platform for in vitro selection of modified aptamers for therapeutic and diagnostic use. It also engages in the development of non-systemic therapies for use in treating patients suffering from neurolo...[Read more]

Industry

Biotechnology

IPO Date

2018-12-01

Stock Exchange

WSE

Ticker

PUR.WA

The Current Ratio as of December 2025 (TTM) for Pure Biologics Spólka Akcyjna (PUR.WA) is 0.13

According to Pure Biologics Spólka Akcyjna’s latest financial reports and current stock price. The company's current Current Ratio is 0.13. This represents a change of -66.49% compared to the average of 0.39 of the last 4 quarters.

Pure Biologics Spólka Akcyjna (PUR.WA) Historical Current Ratio (quarterly & annually)

How has PUR.WA Current Ratio performed in the past?

The mean historical Current Ratio of Pure Biologics Spólka Akcyjna over the last ten years is 1.99. The current 0.13 Current Ratio has changed 560.08% with respect to the historical average. Over the past ten years (40 quarters), PUR.WA's Current Ratio was at its highest in in the December 2021 quarter at 7.75. The Current Ratio was at its lowest in in the September 2017 quarter at 0.

Quarterly (TTM)
Annual

Average

1.99

Median

1.46

Minimum

0.14

Maximum

7.75

Pure Biologics Spólka Akcyjna (PUR.WA) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Pure Biologics Spólka Akcyjna Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 970.20%

Maximum Annual Current Ratio = 7.75

Minimum Annual Increase = -94.96%

Minimum Annual Current Ratio = 0.14

Quarterly (TTM)
Annual
YearCurrent RatioChange
20240.14-94.96%
20232.7043.49%
20221.88-75.70%
20217.75970.20%
20200.72-53.15%
20191.555.62%
20181.4658.84%
20170.9217.43%

Pure Biologics Spólka Akcyjna (PUR.WA) Average Current Ratio

How has PUR.WA Current Ratio performed in the past?

The current Current Ratio of Pure Biologics Spólka Akcyjna (PUR.WA) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

1.57

5-year avg

2.64

10-year avg

1.99

Pure Biologics Spólka Akcyjna (PUR.WA) Current Ratio vs. Peers

How is PUR.WA’s Current Ratio compared to its peers?

Pure Biologics Spólka Akcyjna’s Current Ratio is less than Urteste S.A. (10.31), less than Pharmena S.A. (13.18), greater than Airway Medix S.A. (0.12), less than BioMaxima S.A. (1.44), less than NanoGroup S.A. (1.40), less than Genomtec S.A. (3.08), less than Poltreg S.A. (3.09), less than Mabion S.A. (0.82), greater than Adiuvo Investments S.A. (0.13), less than Molecure S.A. (10.28),

Build a custom stock screener for Pure Biologics Spólka Akcyjna (PUR.WA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pure Biologics Spólka Akcyjna using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pure Biologics Spólka Akcyjna (PUR.WA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pure Biologics Spólka Akcyjna or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Pure Biologics Spólka Akcyjna's Current Ratio?

How is the Current Ratio calculated for Pure Biologics Spólka Akcyjna (PUR.WA)?

What is the highest Current Ratio for Pure Biologics Spólka Akcyjna (PUR.WA)?

What is the 3-year average Current Ratio for Pure Biologics Spólka Akcyjna (PUR.WA)?

What is the 5-year average Current Ratio for Pure Biologics Spólka Akcyjna (PUR.WA)?

How does the current Current Ratio for Pure Biologics Spólka Akcyjna (PUR.WA) compare to its historical average?